Interpretation of the official instructions for apalutamide (Ansenko) and patient medication instructions

1. Drug introduction and mechanism of action

Apalutamide (Apalutamide) is a nonsteroidal androgen receptor antagonist (AR antagonist). It competitively binds to the androgen receptor (AR) and prevents androgens (such as testosterone) from binding to the receptor, thereby inhibiting the growth and spread of prostate cancer cells. Compared with traditional androgen-blocking drugs, apalutamide can more effectively inhibit the AR signaling pathway and delay tumor progression. It is especially suitable for patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and partially metastatic castration-resistant prostate cancer (mCRPC).

Apalutamide is usually used in combination with **castration therapy (ADT)** to achieve stronger anti-tumor effects by inhibiting the androgen pathway through multiple targets. Its oral formulation is convenient for patients to take on their own in outpatient clinics, improving compliance.

2. Main indications

According to the official instructions, apalutamide is mainly suitable for the following groups of people:

1.Non-metastatic castration-resistant prostate cancer (nmCRPC): The patient's serum prostate-specific antigen (PSA) level is elevated, and castration therapy (such as GnRH agonist or castration surgery) still fails to effectively control the tumor.

2.Metastatic castration-resistant prostate cancer (mCRPC): Some guidelines allow use under specific clinical conditions to delay disease progression.

3.Combined treatment plan: Apalutamide needs to be used in combination with castration therapy to ensure that androgen levels remain low and improve the therapeutic effect.

Clinical studies have shown that apalutamide can significantly prolong bone metastasis-free survival (MFS) and progression-free survival (PFS), and improve patients' quality of life to a certain extent.

3. Usage, dosage and correct dosage guidance

1.Regular dosage

Apalutamide oral tablet, recommended dose is 240 mg daily 240 mg(4Tablets, each tablet60 mg), taken orally at one time or in divided doses;

It should be swallowed with water, and can be taken on an empty stomach or after meals, but avoid taking it with grapefruit or grapefruit juice at the same time to avoid affecting drug metabolism.

2.Treatment and adjustments

Patients should take apalutamide long-term until disease progression or intolerable side effects occur;

If serious adverse reactions occur, such as severe rash, liver function abnormalities or cardiac events, the drug needs to be temporarily discontinued or the dose reduced, and then resumed after the symptoms are relieved.

3.Notes

Avoid stopping medication or missing doses without authorization to preventPSA rapid rebound and tumor progression;

Be careful when using it in combination with other drugsCYP3A4, CYP2C8 drug interactions, such as antifungals, antiviral drugs and certain antibiotics;

It is contraindicated for pregnant women and male patients of childbearing age should take contraceptive measures to avoid potential fetal risks.

4. Side effects and management

1.Common side effects of apalutamide include:

Skin and mucous membrane reactions: rash, itching, desquamation, and some patients may be accompanied by mild fever or joint pain;

Fatigue and central nervous system reactions: fatigue, dizziness, increased risk of falls;

Blood pressure and cardiovascular reactions: hypertension, arrhythmia, some patients need to monitor blood pressure and electrocardiogram;

Endocrine and metabolic effects: Some patients experience weight gain, blood sugar or dyslipidemia;

Fractures and musculoskeletal symptoms: Long-term medication may affect bone density, so calcium and vitamin D need to be supplemented.

2.Key points of safety management:

Regularly monitor blood routine, liver and kidney function, blood pressure and electrocardiogram;

If serious side effects occur, you should seek medical treatment promptly and communicate with the attending physician on the dose adjustment plan;

Avoid concomitant use with other potentially cardiotoxic drugs.

5. Patient medication instructions and life guidance

Compliance management: Take medication on time every day and do not adjust the dose or stop medication on your own;

Diet and Drug Interactions: Avoid grapefruit and high-dose vitaminsC, supplements affect metabolism;

Exercise and bone protection: moderate exercise, calcium supplementation, vitaminsDand bone protection drugs when necessary;

Symptom monitoring: Timely record skin rash, fatigue, falls, heart palpitations and bone pain so that doctors can adjust treatment plans.

Overall, apalutamide provides significant clinical benefits to patients with castration-resistant prostate cancer through precise inhibition of the androgen receptor signaling pathway. Combined with standardized medication guidance, regular follow-up and lifestyle management, the best efficacy can be achieved while ensuring safety.

Reference link:https://www.drugs.com